Clinical trial
Furcation Therapy With Enamel Matrix Derivative: Effects on the Subgingival Microbiome
NCT02907528 is registered in ClinicalTrials.gov with Ohio State University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Furcation Therapy With Enamel Matrix Derivative: Effects on the Subgingival Microbiome
- Lead sponsor
- Ohio State University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- January 31, 2016
- Enrollment
- 39 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.